Adolescent self-screening for contraindications to combined oral contraceptive pills

Rc, Williams; Hensel, Devon J.; Lehmann, Audrey; Sarin, Tara; Shew, Marcia L.; Ott, Mary A.

doi:10.1016/j.contraception.2015.06.109

Cited by 6 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerns related to parental consent were raised by participants of this study, as were potential positive experiences for young women. While not voiced during this study, the ability of adolescents to accurately recall their own medical history and independently consent to medical treatment is often a cited concern with the expansion of medical policy to young people . Ongoing research continues to demonstrate that adolescents have the ability and capacity to accurately self‐screen for appropriate use of hormonal contraception .…”

Section: Discussionmentioning

confidence: 92%

“…While not voiced during this study, the ability of adolescents to accurately recall their own medical history and independently consent to medical treatment is often a cited concern with the expansion of medical policy to young people . Ongoing research continues to demonstrate that adolescents have the ability and capacity to accurately self‐screen for appropriate use of hormonal contraception . Additional research is needed, with consideration given for including this vulnerable population in any policies that enhance access to contraception.…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

Women's perceptions of pharmacist‐prescribed hormonal contraception

Meredith

Olenik

Farris

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction Unintended pregnancy is a public health issue, with young women in their late teens and early 20s at highest risk. Multiple approaches to increasing contraception access have been implemented, including adoption of statewide pharmacist prescribing legislation in multiple states. Indiana does not currently have such legislation in place. The objective of this study was to identify how women at risk for unintended pregnancy in central Indiana perceive pharmacist prescribing of contraception. Study Design Qualitative, one‐on‐one semi‐structured interviews. Methods Purposive, convenience sampling of eligible women 18 to 29‐years‐old who live in Indiana was used. Recruitment occurred via printed flyers placed in public locations that were not focused on health care, free classified online advertisements, and electronic flyers within Facebook social groups relevant to the study population. Interviews were conducted via telephone until thematic saturation was achieved. Participant demographics, baseline characteristics, current and past barriers to obtaining contraception, and perception of a pharmacist contraception prescribing model were collected. Interview transcripts were coded in an iterative manner with qualitative data analysis software (MAXQDA, Version 12) until consensus was achieved. Results Fourteen women completed the study. Four primary themes emerged encompassing accessibility, communication, pharmacist attributes, and payment. Thirteen participants would personally utilize a pharmacist prescribing contraceptive service and all stated that this service would be beneficial for other women. Of those women expressing a preference (n = 7), a female pharmacist would be preferred for service delivery. Participants expressed concerns related to access by minors, skills and training of the pharmacist, and environment within the pharmacy. Conclusions Women in Indiana desire broader access to contraception. Efforts should be made at the individual pharmacist‐provider level and statewide to explore strategies to increase access. Resources should be allocated to the creation of protocols for pharmacist prescribing within Indiana and other states.

show abstract

Section: Discussionmentioning

confidence: 92%

Section: Discussionmentioning

confidence: 96%

Women's perceptions of pharmacist‐prescribed hormonal contraception

Meredith

Olenik

Farris

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…The physician who prescribes the COC or the pharmacist who dispenses could provide all women with a formal written risk assessment for contraindications. In addition, we should not ignore the role of self-care; women can self-screen using a checklist of contraindications [33]. Promoting the importance of proper assessment prior to prescribing and considering the alternatives suitable for long-term use such as the copper intrauterine device or progestin-only depot medroxyprogesterone acetate or progestogen-only pill, since they have fewer contraindications than the combined pill among women regularly taking a contraceptive, is recommended [18].…”

Section: Discussionmentioning

confidence: 99%

The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study

Assiri

Bannan

Alshehri

et al. 2022

IJERPH

View full text Add to dashboard Cite

This study aimed to determine the estimated proportion of contraindications among women taking combined oral contraceptives (COCs) and to assess the risk factors associated with their contraindications. This study was cross-sectional. Reproductive-aged women (18–49 years) on any COCs between 2018 and 2020 were recruited from one obstetrics–gynaecology clinic in a university-affiliated hospital and were included. Contraindications were defined using the World Health Organization (WHO) Medical Eligibility Criteria (MEC) for Contraceptive Use. Data were collected from electronic medical records for all included women, as well as a standardised, pretested, structured survey for one-third of the women. In this cross-sectional study, 380 women using COCs were included. Their mean age was 31.645 ± 7.366 years. Among them, 131 (34.5%) participated via a survey and electronic records, while the other 249 (65.5%) participated via electronic records only. The majority of the participants had a Bachelor’s degree (59.0%) and were married (62.1%). The overall estimated proportion of patients with at least one contraindication to COCs according to category 3 (relative contraindications) or 4 (absolute contraindications) was 31.3% (95% CI 26.63–35.99). The most common contraindications observed were controlled hypertension, category 3 (12.1%); major surgery with prolonged immobilisation, category 4 (4.7%); migraine with aura at any age, category 4 (4.2%); breastfeeding from six weeks to less than six months postpartum, category 3 (4.0%); and diabetes mellitus with complications, category 4 (3.2%). Significant factors associated with contraindications to COCs were married women (OR 2.19, 95% CI 1.38–3.46), those aged 35 years or more (OR 2.33, 95% CI 1.49–3.66), and those with one or more live births (OR 2.19, 95% CI 1.38–3.46). Ensuring roper assessment prior to prescribing and considering alternatives suitable for long-term use among women taking an oral contraceptive regularly is recommended.

show abstract

“…The physician who prescribes the COC or the pharmacist who dispenses them could provide all women with a formal written risk assessment for contraindications [31]. In addition, we should not ignore the role of self-care; women can self-screen using a checklist of contraindications [32].…”

Section: Discussionmentioning

confidence: 99%

A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk

Vinciguerra

Cascardi

Marrone

et al. 2023

JPM

View full text Add to dashboard Cite

Combined oral contraceptives (COC), are among the most widely used contraceptive methods in the world today. Despite the different changes in terms of estrogen/progestogen combinations and dosages, the thromboembolic risk for a woman who takes combined oral contraceptives persists to date. Methods: The review of relevant literature and international guidelines on prescription of combined oral contraceptives made it possible to create a proposal for informed consent to be used for prescribing. Results: The several sections of our consent proposal were designed according to a rationale in order to cover all the aspects presented by worldwide guidelines: how to take, adverse effects, advertisements, extra-contraceptive benefits and effects, a checklist for condition at risk of thromboembolism, the signature of the woman. Conclusions: An informed consent to standardize combined oral contraceptives prescription can improve women’s eligibility, mitigate thromboembolic risk, and assure legal protection to healthcare providers. In this systematic review in particular, we refer to the Italian medical–legal scenario, to which our group of researchers belongs. However, the model proposed was designed in the respect of main healthcare organization guidelines, and it could be easily used by any center in the world.

show abstract

Adolescent self-screening for contraindications to combined oral contraceptive pills

Cited by 6 publications

References 0 publications

Women's perceptions of pharmacist‐prescribed hormonal contraception

Women's perceptions of pharmacist‐prescribed hormonal contraception

The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study

A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk

Contact Info

Product

Resources

About